Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the Company will be hosting its first-ever Investor & Analyst Day event on Wednesday, June 18, 2025. The event will take place at Myomo's new corporate headquarters and manufacturing facility in Burlington, Mass., and will offer an in-depth look at the Company's latest innovations, strategic plans and growth initiatives to empower individuals with neuromuscular disorders through cutting-edge wearable medical robotics.
Institutional investors, shareholders and analysts are invited to register here to attend the event in-person. The event will also be webcast live and available for replay.
What to Expect:
- Presentations from Myomo's senior management on recent achievements, upcoming milestones, performance metrics and objectives, product innovations, commercial channels and growth strategy
- Demonstrations showcasing the technology behind the MyoPro® powered arm and hand brace and the patient evaluation process
- Q&A sessions with key executives
- A guided tour of Myomo's new corporate headquarters and manufacturing facility
- Networking opportunities with Myomo's senior management
Event: |
Investor & Analyst Day |
Date: |
Wednesday, June 18, 2025 |
Time: |
10:00 a.m. - 3:00 p.m. ET, including a facilities tour for in-person attendees |
Location: |
Conference Center, 55 Blue Sky Dr., 1st floor, Burlington, MA 01803 |
In-person Registration: |
|
Virtual Webcast: |
A note for in-person attendees: Myomo's headquarters is located approximately 22 miles from Boston's Logan Airport. For those needing overnight accommodations, a room block has been reserved for Tuesday, June 17, at the Boston Marriott Burlington, located at One Burlington Mall Road, Burlington, Mass., 01803. To reserve a room, please use this reservation link. Lunch will be available during the event.
About Myomo
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Mass., with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250501637581/en/
Myomo:
[email protected]
Alliance Advisors IR:
Tirth T. Patel
[email protected]
212-201-6614